Most probably, the presence of truncated CSF3R and RUNX1 mutations in HSPCs of CN patients alters the pro-inflammatory cell state, enhances proliferation, and increases the susceptibility of HSPCs to genomic toxicity. Here, CSF3R is linked to cyclic hematopoiesis.